Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling

Future Oncology, Ahead of Print.

Source: Future Oncology - May 11, 2018 Category: Cancer & Oncology Authors: Peter Reichardt Marie-Dominique Tabone Jaume Mora Bruce Morland Robin L Jones Source Type: research